tiprankstipranks
Trending News
More News >
Huakang Biomedical Holdings Company Limited (HK:8622)
:8622
Hong Kong Market

Huakang Biomedical Holdings Company Limited (8622) Financial Statements

Compare
0 Followers

Huakang Biomedical Holdings Company Limited Financial Overview

Huakang Biomedical Holdings Company Limited's market cap is currently HK$202.69M. The company's EPS TTM is HK$; its P/E ratio is ―; Huakang Biomedical Holdings Company Limited is scheduled to report earnings on May 13, 2025, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue¥ 25.36M¥ 24.63M¥ 25.33M¥ 26.13M¥ 21.97M
Gross Profit¥ 17.07M¥ 16.09M¥ 16.91M¥ 16.46M¥ 14.72M
Operating Income¥ -5.01M¥ -6.48M¥ -2.95M¥ -3.80M¥ -8.74M
EBITDA¥ -3.41M¥ -2.55M¥ 188.00K¥ -852.00K¥ -8.10M
Net Income¥ -4.16M¥ -5.78M¥ -3.08M¥ -4.22M¥ -11.63M
Balance Sheet
Cash & Short-Term Investments¥ 36.49M¥ 32.94M¥ 33.30M¥ 36.21M¥ 41.94M
Total Assets¥ 65.22M¥ 65.31M¥ 66.40M¥ 67.06M¥ 72.70M
Total Debt¥ 4.08M¥ 5.14M¥ 469.00K¥ 1.68M¥ 2.64M
Net Debt¥ -27.41M¥ -27.80M¥ -32.83M¥ -34.52M¥ -39.30M
Total Liabilities¥ 11.17M¥ 14.30M¥ 9.88M¥ 9.36M¥ 10.84M
Stockholders' Equity¥ 54.05M¥ 51.02M¥ 56.52M¥ 57.70M¥ 61.86M
Cash Flow
Free Cash Flow¥ 0.00¥ -1.55M¥ 475.00K¥ -4.71M¥ -6.00M
Operating Cash Flow¥ 0.00¥ -48.00K¥ 1.29M¥ -2.38M¥ -3.92M
Investing Cash Flow¥ 0.00¥ -1.15M¥ -6.11M¥ -2.06M¥ -1.94M
Financing Cash Flow¥ 0.00¥ 1.02M¥ 2.32M¥ -1.37M¥ -1.11M
Currency in CNY

Huakang Biomedical Holdings Company Limited Earnings and Revenue History

Huakang Biomedical Holdings Company Limited Debt to Assets

Huakang Biomedical Holdings Company Limited Cash Flow

Huakang Biomedical Holdings Company Limited Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis